These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12135534)

  • 1. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K; Ackenheil M
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):111-3. PubMed ID: 12135534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.
    Krause KH; Dresel SH; Krause J; la Fougere C; Ackenheil M
    Neurosci Biobehav Rev; 2003 Nov; 27(7):605-13. PubMed ID: 14624805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
    Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
    Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
    Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
    Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K
    Neurosci Lett; 2000 May; 285(2):107-10. PubMed ID: 10793238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
    Krause J
    Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
    da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
    van Dyck CH; Quinlan DM; Cretella LM; Staley JK; Malison RT; Baldwin RM; Seibyl JP; Innis RB
    Am J Psychiatry; 2002 Feb; 159(2):309-12. PubMed ID: 11823278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter density in patients with attention deficit hyperactivity disorder.
    Dougherty DD; Bonab AA; Spencer TJ; Rauch SL; Madras BK; Fischman AJ
    Lancet; 1999 Dec 18-25; 354(9196):2132-3. PubMed ID: 10609822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.
    Krause KH; Dresel S; Krause J; Kung HF; Tatsch K; Lochmüller H
    J Neurol; 2002 Aug; 249(8):1116-8. PubMed ID: 12420715
    [No Abstract]   [Full Text] [Related]  

  • 16. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder.
    la Fougère C; Krause J; Krause KH; Josef Gildehaus F; Hacker M; Koch W; Hahn K; Tatsch K; Dresel S
    Nucl Med Commun; 2006 Sep; 27(9):733-7. PubMed ID: 16894328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
    Martinez D; Gelernter J; Abi-Dargham A; van Dyck CH; Kegeles L; Innis RB; Laruelle M
    Neuropsychopharmacology; 2001 May; 24(5):553-60. PubMed ID: 11282255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine transporter and attention-deficit/hyperactivity disorder.
    Madras BK; Miller GM; Fischman AJ
    Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine.
    Krause J; Krause KH; Dresel SH; la Fougere C; Ackenheil M
    Dialogues Clin Neurosci; 2006; 8(1):29-36. PubMed ID: 16640111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.